Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
20/09/2024 | 22:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:VCEL | Vericel Corporation |
18/09/2024 | 22:10 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:VCEL | Vericel Corporation |
29/08/2024 | 15:17 | GlobeNewswire Inc. | Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024 | NASDAQ:VCEL | Vericel Corporation |
26/08/2024 | 14:03 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:VCEL | Vericel Corporation |
26/08/2024 | 13:45 | GlobeNewswire Inc. | Vericel Announces FDA Approval and Commercial Availability of MACI Arthro | NASDAQ:VCEL | Vericel Corporation |
16/08/2024 | 22:06 | Edgar (US Regulatory) | Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers | NASDAQ:VCEL | Vericel Corporation |
15/08/2024 | 22:05 | GlobeNewswire Inc. | Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns | NASDAQ:VCEL | Vericel Corporation |
07/08/2024 | 14:30 | GlobeNewswire Inc. | Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024 | NASDAQ:VCEL | Vericel Corporation |
01/08/2024 | 15:05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:VCEL | Vericel Corporation |
01/08/2024 | 13:55 | GlobeNewswire Inc. | Vericel Reports Second Quarter 2024 Financial Results | NASDAQ:VCEL | Vericel Corporation |
22/07/2024 | 14:30 | GlobeNewswire Inc. | Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer | NASDAQ:VCEL | Vericel Corporation |
18/07/2024 | 14:30 | GlobeNewswire Inc. | Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024 | NASDAQ:VCEL | Vericel Corporation |
11/06/2024 | 14:30 | GlobeNewswire Inc. | Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024 | NASDAQ:VCEL | Vericel Corporation |
22/05/2024 | 14:30 | GlobeNewswire Inc. | Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024 | NASDAQ:VCEL | Vericel Corporation |
08/05/2024 | 13:55 | GlobeNewswire Inc. | Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance | NASDAQ:VCEL | Vericel Corporation |
24/04/2024 | 14:30 | GlobeNewswire Inc. | Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024 | NASDAQ:VCEL | Vericel Corporation |
29/02/2024 | 15:04 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:VCEL | Vericel Corporation |
29/02/2024 | 13:55 | GlobeNewswire Inc. | Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance | NASDAQ:VCEL | Vericel Corporation |
27/02/2024 | 14:30 | GlobeNewswire Inc. | Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024 | NASDAQ:VCEL | Vericel Corporation |
15/02/2024 | 14:30 | GlobeNewswire Inc. | Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024 | NASDAQ:VCEL | Vericel Corporation |
14/02/2024 | 13:42 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:VCEL | Vericel Corporation |
13/02/2024 | 12:01 | Edgar (US Regulatory) | Form 5 - Annual statement of changes in beneficial ownership of securities | NASDAQ:VCEL | Vericel Corporation |
05/02/2024 | 14:30 | GlobeNewswire Inc. | Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024 | NASDAQ:VCEL | Vericel Corporation |
09/01/2024 | 13:55 | GlobeNewswire Inc. | Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results | NASDAQ:VCEL | Vericel Corporation |
03/01/2024 | 14:30 | GlobeNewswire Inc. | Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 | NASDAQ:VCEL | Vericel Corporation |
08/12/2023 | 22:39 | Edgar (US Regulatory) | Form 144/A - Report of proposed sale of securities: [Amend] | NASDAQ:VCEL | Vericel Corporation |
08/11/2023 | 13:55 | GlobeNewswire Inc. | Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance | NASDAQ:VCEL | Vericel Corporation |
07/11/2023 | 14:30 | GlobeNewswire Inc. | Vericel to Present at the Stephens Annual Investment Conference | NASDAQ:VCEL | Vericel Corporation |
25/10/2023 | 14:30 | GlobeNewswire Inc. | Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023 | NASDAQ:VCEL | Vericel Corporation |
28/09/2023 | 14:30 | GlobeNewswire Inc. | Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid | NASDAQ:VCEL | Vericel Corporation |